Hikal Limited (BOM:524735)
199.95
-0.55 (-0.27%)
At close: Jan 22, 2026
Hikal Revenue
Hikal had revenue of 3.19B INR in the quarter ending September 30, 2025, a decrease of -29.68%. This brings the company's revenue in the last twelve months to 16.99B, down -6.72% year-over-year. In the fiscal year ending March 31, 2025, Hikal had annual revenue of 18.60B with 4.21% growth.
Revenue (ttm)
16.99B
Revenue Growth
-6.72%
P/S Ratio
1.41
Revenue / Employee
8.24M
Employees
2,062
Market Cap
23.92B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 18.60B | 752.00M | 4.21% |
| Mar 31, 2024 | 17.85B | -2.38B | -11.79% |
| Mar 31, 2023 | 20.23B | 803.09M | 4.13% |
| Mar 31, 2022 | 19.43B | 2.22B | 12.92% |
| Mar 31, 2021 | 17.20B | 2.13B | 14.14% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Unichem Laboratories | 22.26B |
| FDC Limited | 20.77B |
| Morepen Laboratories | 17.56B |
| Gufic Biosciences | 8.74B |
| Bliss GVS Pharma | 8.60B |
| TTK Healthcare | 8.25B |
| Syncom Formulations (India) | 5.15B |
| Amrutanjan Health Care | 4.70B |
Hikal News
- 7 weeks ago - Hikal shares rally over 12% today; Details here - Business Upturn
- 2 months ago - Hikal Ltd (BOM:524735) Q2 2026 Earnings Call Highlights: Navigating Challenges and Seizing ... - GuruFocus
- 2 months ago - Q2 2026 Hikal Ltd Earnings Call Transcript - GuruFocus
- 2 months ago - Hikal shares fall over 5% as company reports Q2 net loss and nearly 30% drop in sales - Business Upturn
- 2 months ago - Stocks under radar today: Titagarh Rail, Polyplex, Hikal, Maithan Alloys, NIACL and more - Business Upturn
- 4 months ago - Baba Kalyani's son retains Hikal board seat amid feud - The Times of India
- 5 months ago - Hikal shares fall over 2% after US FDA issues warning letter for Jigani facility - Business Upturn
- 5 months ago - Hikal receives warning letter from US FDA for Jigani facility - Business Upturn